Antimycobacterial Effect of Selenium Nanoparticles on
antimycobacterial effect
cell wall damaging agents
mycobacterium tuberculosis
selenium nanoparticles
smegmatis
Journal
Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977
Informations de publication
Date de publication:
2020
2020
Historique:
received:
24
02
2020
accepted:
03
04
2020
entrez:
20
5
2020
pubmed:
20
5
2020
medline:
20
5
2020
Statut:
epublish
Résumé
Tuberculosis (TB) remains the leading cause of death from a single infection agent worldwide. In recent years, the occurrence of TB cases caused by drug-resistant strains has spread, and is expected to continue to grow. Therefore, the development of new alternative treatments to the use of antibiotics is highly important. In that sense, nanotechnology can play a very relevant role, due to the unique characteristics of nanoparticles. In fact, different types of nanoparticles have already been evaluated both as potential bactericides and as efficient drug delivery vehicles. In this work, the use of selenium nanoparticles (SeNPs) has been evaluated to inhibit the growth of two types of mycobacteria:
Identifiants
pubmed: 32425916
doi: 10.3389/fmicb.2020.00800
pmc: PMC7212347
doi:
Types de publication
Journal Article
Langues
eng
Pagination
800Informations de copyright
Copyright © 2020 Estevez, Palacios, Gil, Anguita, Vallet-Regi, González, Prados-Rosales and Luque-Garcia.
Références
Langmuir. 2010 Nov 16;26(22):17617-23
pubmed: 20964304
Nanoscale. 2019 Aug 8;11(31):14937-14951
pubmed: 31363721
PLoS One. 2017 May 18;12(5):e0177987
pubmed: 28542623
Int J Nanomedicine. 2017 Feb 14;12:1227-1249
pubmed: 28243086
Int J Antimicrob Agents. 2015 Aug;46(2):183-8
pubmed: 26009020
Rev Sci Tech. 2018 Dec;37(3):823-830
pubmed: 30964466
J Trace Elem Med Biol. 2015 Jan;29:235-41
pubmed: 25175509
Int J Nanomedicine. 2011;6:1553-8
pubmed: 21845045
Mater Sci Eng C Mater Biol Appl. 2018 Dec 1;93:838-845
pubmed: 30274119
Front Microbiol. 2018 Mar 09;9:422
pubmed: 29593676
Evid Based Complement Alternat Med. 2015;2015:246012
pubmed: 25861355
Int J Mol Sci. 2019 Aug 04;20(15):
pubmed: 31382674
Curr Drug Metab. 2017;18(2):120-128
pubmed: 27908256
Int J Nanomedicine. 2018 Apr 10;13:2107-2128
pubmed: 29692609
Curr Drug Metab. 2017;18(11):1040-1054
pubmed: 28952436
Recent Pat Nanotechnol. 2020 Mar 13;:
pubmed: 32167434
J Nanosci Nanotechnol. 2014 Jan;14(1):946-57
pubmed: 24730311
Colloids Surf B Biointerfaces. 2014 Oct 1;122:184-193
pubmed: 25038448
Microb Pathog. 2017 Sep;110:335-344
pubmed: 28710015
PLoS One. 2010 May 24;5(5):e10777
pubmed: 20520722
Int J Mycobacteriol. 2018 Jan-Mar;7(1):84-88
pubmed: 29516891
J Genet Eng Biotechnol. 2018 Jun;16(1):1-8
pubmed: 30647697
Chem Commun (Camb). 2015 Aug 4;51(60):12028-31
pubmed: 26121049
Biomed Pharmacother. 2019 Mar;111:802-812
pubmed: 30616079